Colostage Test
CRC recurrence
ColoStage  geneset
Hepatocellular Carcinoma ColoStage
HCC
new prognosis test
new prognostic test
formation of recurrent CRC
companion diagnostic test
primary tumor
high TGF-beta
TGF-beta status
therapeutic intervention
Colorectal Cancer
risk of disease relapse
novel gene expression signature
primary treatment
new cases
prediction of metastasis
limited power
potential use
competitive use
predictive power
recurrence probability
clinical trials
clinical setting
poor prognosis
diagnosed cancers
current staging systems
time of diagnosis
aggressiveness
surgical resection
independent cohort of patient samples
existing drug therapies safer
selection of patients
Calon
Dx
pathway
accurate method
developed drugs
types of tumors
Prescription of chemotherapy
validation
proposal
resources